Medicare Enrolled
Dr. Mehnaz Junagadhwalla, MD
Hematology · Englewood, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Junagadhwalla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Junagadhwalla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Junagadhwalla
Dr. Mehnaz Junagadhwalla is a hematology specialist in Englewood, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Junagadhwalla performed 187,273 Medicare services across 5,733 unique beneficiaries.
Between the years covered by Open Payments, Dr. Junagadhwalla received a total of $10,382 from 70 pharmaceutical and/or device companies across 527 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Junagadhwalla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 23% volume in FL
$10,382 industry payments
Medicare Practice Summary
Medicare Utilization ↗187,273
Medicare services
Top 23% in FL for hematology
5,733
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,404 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
24,631 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
24,540 | $0 | $2 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
20,400 | $0 | $4 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
18,660 | $0 | $1 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
17,700 | $0 | $12 |
| Anti-nausea injection (aprepitant) | 16,770 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 11,400 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 10,260 | $19 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
7,801 | $6 | $23 |
| Paclitaxel chemotherapy injection | 6,494 | $0 | $2 |
| Iron infusion (Monoferric) | 4,200 | $16 | $57 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,972 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,856 | $8 | $9 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
2,772 | $26 | $116 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,576 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,580 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,564 | $95 | $339 |
| Injection, leucovorin calcium, per 50 mg | 1,278 | $3 | $12 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
997 | $10 | $69 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
882 | $2 | $7 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
491 | $98 | $378 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
475 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 468 | $0 | $9 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
466 | $1 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
430 | $22 | $84 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
378 | $1 | $6 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
315 | $17 | $59 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
310 | $48 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $65 | $239 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
284 | $2 | $41 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
253 | $15 | $56 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
248 | $54 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
185 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
175 | $21 | $79 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
152 | $172 | $550 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
134 | $10 | $42 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 134 | $401 | $680 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
131 | $49 | $178 |
| New patient office visit, complex (60-74 min) | 113 | $159 | $585 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
109 | $1,097 | $3,706 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
106 | $135 | $474 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
106 | $127 | $637 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
93 | $2 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
92 | $2 | $8 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
91 | $25 | $156 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
88 | $15 | $56 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
79 | $4 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 68 | $132 | $562 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
63 | $53 | $206 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
63 | $42 | $170 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
55 | $25 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $122 | $453 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
44 | $45 | $350 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
43 | $4 | $15 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
43 | $1 | $7 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $63 | $197 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
38 | $28 | $156 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
36 | $197 | $708 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
31 | $1,098 | $3,706 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $137 | $556 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
26 | $78 | $391 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
26 | $68 | $277 |
| CT scan of neck soft tissue with contrast A computed tomography scan that uses contrast dye to create detailed images of the soft tissues in the neck. |
22 | $71 | $704 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
20 | $102 | $467 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $94 | $285 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
12 | $5 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.2% high complexity
81.1% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,382
Total received (2018-2024)
Avg $1,483/year across 7 years
Top 41% in FL for hematology
70
Companies
527
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,026 (96.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$356 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,406
2023
$2,426
2022
$2,174
2021
$681
2020
$269
2019
$1,278
2018
$1,147
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$797
E.R. Squibb & Sons, L.L.C.
$677
PFIZER INC.
$660
Genentech USA, Inc.
$627
Celgene Corporation
$529
Merck Sharp & Dohme LLC
$436
Daiichi Sankyo Inc.
$412
Incyte Corporation
$388
BeiGene USA, Inc.
$383
Lilly USA, LLC
$345
Astellas Pharma US Inc
$326
Gilead Sciences, Inc.
$305
Janssen Biotech, Inc.
$302
Amgen Inc.
$289
Regeneron Healthcare Solutions, Inc.
$258
Seagen Inc.
$256
GENZYME CORPORATION
$251
Merck Sharp & Dohme Corporation
$234
Bayer Healthcare Pharmaceuticals Inc.
$173
AstraZeneca Pharmaceuticals LP
$157
JAZZ PHARMACEUTICALS INC.
$146
EMD Serono, Inc.
$136
Exelixis Inc.
$131
Acrotech Biopharma Inc.
$125
Kite Pharma, Inc.
$115
GlaxoSmithKline, LLC.
$103
Ipsen Biopharmaceuticals, Inc
$102
Takeda Pharmaceuticals U.S.A., Inc.
$91
ARRAY BIOPHARMA INC
$90
Mirati Therapeutics, Inc.
$81
ADC Therapeutics America, Inc.
$80
Bayer HealthCare Pharmaceuticals Inc.
$75
ABBVIE INC.
$74
Sumitomo Pharma America, Inc.
$72
Eisai Inc.
$68
Pharmacyclics LLC, An AbbVie Company
$63
AVEO Pharmaceuticals, Inc.
$54
TAIHO ONCOLOGY, INC.
$51
Genentech, Inc.
$50
RECORDATI_RARE_DISEASES_INC.
$47
Pharmacyclics LLC, an AbbVie Company
$46
Puma Biotechnology, Inc.
$46
Heron Therapeutics, Inc.
$44
Rigel Pharmaceuticals, Inc.
$42
PharmaEssentia USA Corporation
$42
Deciphera Pharmaceuticals Inc.
$42
Dendreon Pharmaceuticals LLC
$40
Blueprint Medicines Corporation
$34
Karyopharm Therapeutics Inc.
$33
Aveo Pharmaceuticals, Inc.
$33
AbbVie, Inc.
$32
Legend Biotech USA Inc.
$31
INSYS Therapeutics Inc
$29
Clovis Oncology, Inc.
$28
Stemline Therapeutics Inc.
$26
SERVIER PHARMACEUTICALS LLC
$25
PUMA BIOTECHNOLOGY, INC.
$25
Alnylam Pharmaceuticals Inc.
$22
Shire North American Group Inc
$21
SOBI, INC
$20
Janssen Pharmaceuticals, Inc
$20
G1 Therapeutics, Inc.
$19
GE HealthCare
$19
Agios Pharmaceuticals, Inc.
$18
Dova Pharmaceuticals
$17
CTI BioPharma Corp.
$15
Spectrum Pharmaceuticals Inc.
$15
Myovant Sciences Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
Array BioPharma Inc.
$13
Top 3 companies account for 20.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENLYSTA · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · Enhertu · Erleada · FASENRA · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · HYQVIA · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SUSTOL · SUTENT · SYLVANT · SYNDROS · Stivarga · TABRECTA · TASIGNA · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
16
Per 100K population
3.6
County median income
$80,633
Nearest hospital
HCA FLORIDA ENGLEWOOD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Junagadhwalla is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Junagadhwalla experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Junagadhwalla performed 24,631 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Junagadhwalla receive payments from pharmaceutical companies?
Yes. Dr. Junagadhwalla received a total of $10,382 from 70 companies across 527 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Junagadhwalla's costs compare to other hematologists in Englewood?
Dr. Junagadhwalla's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Junagadhwalla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Englewood
Browse hematologists in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology